전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Marie Svane, Inge"]
총 15건 
※ 중복 레코드가 제거된 검색 결과가 표시됩니다.
1/2 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (13)
    • Magazines (2)

    재검색

  • 주제
    • melanoma (8)
    • adoptive (3)
    • immunotherapy (3)

    더보기

    재검색

  • 간행물
    • journal for immunotherapy of cancer (13)
    • biomed research international (1)
    • current cancer therapy reviews (1)

    재검색

  • 출판사
    • bmj publishing group ltd (9)
    • bmj publishing group (4)

    재검색

  • 언어
    • english (13)

    재검색

  • 수록데이터베이스
    • MEDLINE (9)
    • Science Citation Index Expanded (4)
    • Supplemental Index (2)

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

5
Therapeutic Cancer Vaccines 미리보기

정기출판물

issue
Current Cancer Therapy Reviews; May 2010, Vol. 6 Issue: 2 p163-174, 12p
Author
Kiaer Larsen, Stine
Marie Svane, Inge
thor Straten, Per
Hald Andersen, Mads
DB Label
Database : Supplemental Index
원문보기
Full Text (Bentham Science)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
6
Therapeutic Cancer Vaccines in Combination with Conventional Therapy 미리보기

정기출판물

issue
BioMed Research International; 2010, Vol. 2010 Issue: 1
Author
Hald Andersen, Mads
Junker, Niels
Ellebaek, Eva
Marie Svane, Inge
thor Straten, Per
DB Label
Database : Supplemental Index
원문보기
Full Text Full Text (원문보기) 조회 - Impact Factor (JCR) 
7
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma. 미리보기

학술저널

issue
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 May 23; Vol. 12 (5). Date of Electronic Publication: 2024 May 23.
Author
Mørk SK; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark sofie.kirial.moerk@regionh.dk.
Skadborg SK; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.
Albieri B; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Draghi A; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Bol K; Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
Kadivar M; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.
Westergaard MCW; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Stoltenborg Granhøj J; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Borch A; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.
Petersen NV; Evaxion Biotech, Copenhagen, Denmark.
Thuesen N; Evaxion Biotech, Copenhagen, Denmark.
Rasmussen IS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
Andreasen LV; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
Dohn RB; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
Yde CW; Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.
Noergaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark.
Lorentzen T; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.
Soerensen AB; Evaxion Biotech, Copenhagen, Denmark.
Kleine-Kohlbrecher D; Evaxion Biotech, Copenhagen, Denmark.
Jespersen A; Evaxion Biotech, Copenhagen, Denmark.
Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
Kringelum J; Evaxion Biotech, Copenhagen, Denmark.
Donia M; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Hadrup SR; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.
Marie Svane I; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
10
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy. 미리보기

학술저널

issue
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).
Author
Tvingsholm SA; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Frej MS; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark.
Rafa VM; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Hansen UK; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark.
Ormhøj M; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Tyron A; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Jensen AWP; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark.
Kadivar M; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Bentzen AK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Munk KK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Aasbjerg GN; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Ternander JSH; PokeAcell Aps, BioInnovation Institute, Copenhagen, Denmark.
Heeke C; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Tamhane T; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Schmess C; NMI Natural and Medical Science Institute, University of Tübingen, Tubingen, Germany.
Funt SA; Deptartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark.
Kverneland AH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark.
Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Copenhagen, Denmark.
Draghi A; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark.
Jakobsen SN; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark.
Marie Svane I; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Herlev Hospital, Herlev, Denmark.
Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark sirha@dtu.dk.
DB Label
Database : MEDLINE
원문보기
Open Access (PubMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
1 2 
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 166748
  • 127605131